Nov 21, 2016 7:00 am EST Capricor Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference
Nov 10, 2016 4:07 pm EST Capricor Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update
Nov 10, 2016 4:05 pm EST Capricor Therapeutics Announces Plans to Expand Clinical Development Program in Duchenne Muscular Dystrophy to Evaluate Peripheral and Respiratory Muscle Function
Nov 03, 2016 7:00 am EDT Capricor Therapeutics to Hold Third Quarter 2016 Business Update and Financial Results Conference Call and Webcast on Thursday, November 10 at 5:00 p.m. ET
Oct 31, 2016 9:00 am EDT Capricor Therapeutics Presents Positive 12-Month Results from DYNAMIC at TCT 2016
Oct 20, 2016 7:00 am EDT Capricor Therapeutics Awarded Up to $4.2 Million from National Institutes of Health to Evaluate Exosomes for Hypoplastic Left Heart Syndrome
Oct 05, 2016 7:00 am EDT Capricor Therapeutics Completes Enrollment in Phase II ALLSTAR Clinical Trial
Sep 26, 2016 7:00 am EDT Capricor Therapeutics Awarded $2.4 Million from U.S. Department of Defense to Support Manufacturing Process Development for Therapeutic Exosomes
Sep 21, 2016 11:00 am EDT Capricor Therapeutics Announces Closing of Public Offerings Raising Approximately $10.0 Million in Net Proceeds